Key result
Small vessel disease was highly prevalent in hypertrophic cardiomyopathy, with higher SVD scores observed in areas with replacement fibrosis.
Why the study?
The relationship between small vessel disease and replacement-type fibrosis in hypertrophic cardiomyopathy remains unclear.
Case-Control (n=40)
Small vessel disease is a frequent feature in hypertrophic cardiomyopathy regardless of clinical presentation, though its severity is greater in end-stage heart failure and in areas with replacement-type fibrosis.
Answers are grounded in this paper and cite their sources.
SVD may contribute to fibrosis in HCM but should not yet change practice; leaves open its prognostic role pending prospective studies.
Background: Hypertrophic cardiomyopathy (HCM) is characterized by myocardial disarray, small vessel disease (SVD), and fibrosis. The relationship between SVD and replacement-type fibrosis is still unclear. Methods: Histopathologic assessment of replacement-type fibrosis and SVD in HCM patients with either end-stage heart failure (HF) or sudden cardiac death (SCD). Chronic ischemic heart disease (IHD) patients served as controls. Results: Forty HCM hearts, 10 HF and 30 SCD, were studied. Replacement-type fibrosis was detected in all HF and in 57% of SCD cases. In SCD, replacement-type fibrosis was associated with older age, greater septal thickness, SVD prevalence, and score (all p < 0.05). Prevalence of SVD did not show significant differences among SCD, HF, and IHD (73%, 100% and 95%, respectively), while SVD score was higher in HF than IHD and SCD (2.4, 1.95, and 1.18, respectively) and in areas with replacement-type fibrosis vs. those without in HF (3.4 vs. 1.4) and SCD (1.4 vs. 0.8) (all p < 0.05). Conclusions: SVD is a frequent feature in HCM independent of the clinical presentation. A higher SVD score is observed in HCM-HF and in areas with replacement-type fibrosis. Although SVD is part of the HCM phenotype, further remodeling of the microcirculation might occur secondarily to fibrosis.
No takes yet. Share an insight, caveat, or question.
Gaspari et al. (2021) conducted a case-control in Hypertrophic cardiomyopathy (HCM) (n=40). Histopathologic assessment vs. Chronic ischemic heart disease (IHD) patients was evaluated on Small vessel disease (SVD) score (p=<0.05). Small vessel disease was highly prevalent in hypertrophic cardiomyopathy, with higher SVD scores observed in areas with replacement fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: